Impel Pharmaceuticals Inc.

Symbol: IMPL

NASDAQ

0.04

USD

Tržní cena dnes

  • -0.0099

    Poměr P/E

  • 0.0011

    Poměr PEG

  • 0.96M

    MRK Cap

  • 0.00%

    Výnos DIV

Impel Pharmaceuticals Inc. Struktura vedení

Informace o vedení

NázevTitul
Dr. Stephen Bevan Shrewsbury M.B. Ch.B., M.D.Chief Medical Officer
Mr. Adrian AdamsChairman & Chief Executive Officer
Mr. Rajiv AminVice President, Controller & Corporation Sec.
Dr. John H. Leaman M.D.Chief Financial & Bus. Officer
Mr. Adrian AdamsChairman, Chief Executive Officer & President
Ms. Sarah WilleVice President of Human Resources
Dr. John D. Hoekman Ph.D.Co-Founder and Chief Technology & Development Officer
Ms. Jennifer L. BermanVice President of Marketing
Ms. Sarah WilleVice President of Human Resources
Dr. John D. Hoekman Ph.D.Co-Founder and Chief Technology & Development Officer
Ms. Sarah WilleVice President of HR
Mr. Rajiv AminVice President, Controller & Interim Chief Financial Officer
Mr. Rajiv AminVice President, Controller, Interim Chief Financial Officer & Corporation Sec.
Mr. Rajiv AminVice President, Controller, Interim Chief Financial Officer & Corporation Sec.
Mr. Michael W. Kalb CPAChief Financial Officer
Mr. Leonard S. PaolilloInterim President & Chief Executive Officer
Dr. Lynn C. Gold Ph.D.Senior Vice President of Regulatory
Mr. Scott YoumansSenior Vice President of Technical Operations
Ms. Patty BillingsleyVice President of Sales
Mr. Leonard S. PaolilloChief Commercial Officer
Mr. Adrian AdamsChairman, Chief Executive Officer & Pres
Dr. John D. Hoekman Ph.D.Co-Founder and Chief Technology & Devel. Officer